Conference Programme
Click on the titles to open the abstract in a new window
09:30
Registration and coffee
10:00
Introduction from Brett Cochrane, DHT Science Director
10:10
Richard Argent, University of Nottingham
Characterising an animal origin-free in vitro model of the human intestinal epithelium for drug permeability studies (abstract S01)
10:35
Faruk Ramadani, Kings College London
An in vitro culture system to study the development and maintenance of human IgE-secreting plasma cells (abstract S02)
11:00
Anderson Brito da Silva, University of Newcastle upon Tyne
Utilising live human peritumoural brain tissue to understand tumour associated seizures (abstract S03)
11:25
Coffee
11:45
Damon Bevan, University of East Anglia
Development of an ex-vivo human skin model for impaired wound healing in diabetes: initial studies including chemokine expression (abstract S04)
12:10
Cleo White, University of Birmingham
Identification of suitable culture medium for the development of an animal-free oral mucosa model (abstract S05)
12:35
Paul Furlong, Aston University
Multi-modal integration of brain function measurements: Compelling evidence for alternatives to animal experimentation (abstract S06)
13:00
Lunch & Poster session
14:00
Helen McLeod and Robyn Duncan, University of Dundee
The future of Thiel embalmed human cadavers as an alternative to training and testing using animals (abstracts S07 and S08)
14:30
Sara Ferluga, Plymouth University
Phosphoproteomic analysis identifies STAT1 as a novel target in meningioma (abstract S10)
15:00
Coffee
15:40
Geoff Pilkington, University of Portsmouth
‘All human’ in vitro blood brain barrier (BBB) modelling: implications for CNS nanoparticle drug delivery and cancer metastasis studies (abstract S11)
16:10
Helen Wheadon, University of Glasgow
Chronic Myeloid Leukaemia tyrosine kinase inhibitor response classification by quantitative RT-PCR (abstract S12)
16:35
Adrian Biddle, Queen Mary University of London
Developing in vitro model systems with demonstrable relevance to human tumour biology and therapeutic development (abstract S13)
17:00
Closing by Kit Byatt, DHT Chair of the Trustees
17:15
Drinks reception